Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Deferred Taxes (2016 - 2020)

Cumberland Pharmaceuticals' Deferred Taxes history spans 9 years, with the latest figure at $21802.0 for Q4 2020.

  • For Q4 2020, Deferred Taxes changed 0.0% year-over-year to $21802.0; the TTM value through Dec 2020 reached $21802.0, down 66.67%, while the annual FY2020 figure was $21802.0, 66.67% down from the prior year.
  • Deferred Taxes for Q4 2020 was $21802.0 at Cumberland Pharmaceuticals, roughly flat from $21803.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $3.5 million in Q2 2017 and bottomed at -$87210.0 in Q4 2017.
  • The 5-year median for Deferred Taxes is $81886.0 (2018), against an average of $454129.9.
  • The largest YoY upside for Deferred Taxes was 1294.48% in 2016 against a maximum downside of 109.66% in 2016.
  • A 5-year view of Deferred Taxes shows it stood at -$43109.0 in 2016, then tumbled by 102.3% to -$87210.0 in 2017, then surged by 193.9% to $81886.0 in 2018, then crashed by 73.37% to $21803.0 in 2019, then dropped by 0.0% to $21802.0 in 2020.
  • Per Business Quant, the three most recent readings for CPIX's Deferred Taxes are $21802.0 (Q4 2020), $21803.0 (Q4 2019), and $43605.0 (Q1 2019).